The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity
Open Access
- 1 February 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (3) , 1472-1479
- https://doi.org/10.1182/blood-2007-10-117184
Abstract
Studies have shown that the immune system can recognize self-antigens under conditions (eg, cell injury) in which the self-tissue might elaborate immune-activating endogenous danger signals. Uric acid (UA) is an endogenous danger signal recently identified to be released from dying cells. Prior work has shown that UA activates immune effectors of both the innate and adaptive immune system, including neutrophils and cytotoxic T-cell immunity. However, it was unclear whether UA could enhance antibody immunity, which was examined in this study. When added to dying tumor cells or with whole protein antigen, UA increased IgG1-based humoral immunity. Further, UA blocked growth of tumor in subsequent tumor challenge experiments, which depended on CD4, but not CD8, T cells. Sera derived from UA-treated animals enhanced tumor growth, suggesting it had little role in the antitumor response. UA did not signal for T-cell expansion or altered tumor-infiltrating leukocyte populations. Consistent with the lack of T-cell expansion, when applied to dendritic cells, UA suppressed T-cell growth factors but up-regulated B cell–activating cytokines. Understanding the nature of endogenous danger signals released from dying cells may aid in a better understanding of mechanisms of immune recognition of self.Keywords
This publication has 40 references indexed in Scilit:
- Immunological Consequences of Apoptotic Cell PhagocytosisThe American Journal of Pathology, 2007
- Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast TumorsCancer Research, 2007
- MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystalsJournal of Clinical Investigation, 2006
- Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesisCancer Letters, 2005
- neu Antigen-Negative Variants Can Be Generated after neu-Specific Antibody Therapy in neu Transgenic MiceCancer Research, 2004
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003
- The immune system evolved to discriminate infectious nonself from noninfectious selfPublished by Elsevier ,2003
- CD40‐mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupusEuropean Journal of Immunology, 1996
- Biased immunoglobulin variable region gene expression by Ly‐1 B cells due to clonal selectionEuropean Journal of Immunology, 1989
- Human Lymphocytes Making Rheumatoid Factor and Antibody to ssDNA Belong to Leu-1 + B-Cell SubsetScience, 1987